Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04VCF
|
|||
| Former ID |
DNC001609
|
|||
| Drug Name |
ADR58
|
|||
| Drug Type |
Aptamer
|
|||
| Indication | Rheumatoid arthritis [ICD-11: FA20] | Investigative | [1] | |
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Oncostatin-M (OSM) | Target Info | . | [1] |
| KEGG Pathway | Cytokine-cytokine receptor interaction | |||
| PI3K-Akt signaling pathway | ||||
| Jak-STAT signaling pathway | ||||
| NetPath Pathway | IL2 Signaling Pathway | |||
| Pathway Interaction Database | GMCSF-mediated signaling events | |||
| IL3-mediated signaling events | ||||
| WikiPathways | Oncostatin M Signaling Pathway | |||
| Adipogenesis | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Therapeutic applications of aptamers. Expert Opin Investig Drugs. 2008 Jan;17(1):43-60. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.